John J. Rossi
Corporate Officer/Principal bei Beckman Research Institute of The City of Hope
Profil
John J.
Rossi is the founder of Dicerna Pharmaceuticals, Inc. (founded in 2007) and MiNA Therapeutics Ltd.
(founded in 2008).
He currently works as a Professor at Beckman Research Institute of The City of Hope.
Previously, he worked as a Director at Cytogenix, Inc. from 2003 to 2010.
Dr. Rossi holds a doctorate degree from the University of Connecticut.
Aktive Positionen von John J. Rossi
Unternehmen | Position | Beginn |
---|---|---|
Beckman Research Institute of The City of Hope
Beckman Research Institute of The City of Hope Hospital/Nursing ManagementHealth Services Beckman Research Institute of The City of Hope is a world-class cancer treatment and research center that offers unparalleled patient outcomes. The institute is located in Duarte, CA and has subsidiaries in the United States. The institute is dedicated to making a difference in the lives of people with cancer, diabetes, and other serious illnesses through compassion and discovery. The non-profit company is aggressively pursuing ways to help their patients right now and are a worldwide leader in administering clinical trials. The company's patient care and treatment extend across a broad range of departments and services. | Corporate Officer/Principal | 03.12.2009 |
Ehemalige bekannte Positionen von John J. Rossi
Unternehmen | Position | Ende |
---|---|---|
Cytogenix, Inc.
Cytogenix, Inc. Miscellaneous Commercial ServicesCommercial Services CytoGenix, Inc. focuses on development and commercialization of its proprietary technology for identify and silencing disease causing genes and expressing proteins for applications. The company was founded on February 10, 1995 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | 19.11.2010 |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Gründer | - |
DICERNA PHARMACEUTICALS, INC. | Gründer | - |
Ausbildung von John J. Rossi
University of Connecticut | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Cytogenix, Inc.
Cytogenix, Inc. Miscellaneous Commercial ServicesCommercial Services CytoGenix, Inc. focuses on development and commercialization of its proprietary technology for identify and silencing disease causing genes and expressing proteins for applications. The company was founded on February 10, 1995 and is headquartered in Houston, TX. | Commercial Services |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Beckman Research Institute of The City of Hope
Beckman Research Institute of The City of Hope Hospital/Nursing ManagementHealth Services Beckman Research Institute of The City of Hope is a world-class cancer treatment and research center that offers unparalleled patient outcomes. The institute is located in Duarte, CA and has subsidiaries in the United States. The institute is dedicated to making a difference in the lives of people with cancer, diabetes, and other serious illnesses through compassion and discovery. The non-profit company is aggressively pursuing ways to help their patients right now and are a worldwide leader in administering clinical trials. The company's patient care and treatment extend across a broad range of departments and services. | Health Services |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Health Technology |